Mawer Investment Management Ltd. Gilead Sciences, Inc. Transaction History

Mawer Investment Management Ltd.

$20.6 Billion
Q2 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $19.2 Million - $21.9 Million	-339,387 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $21.9 Million - $27.6 Million	-352,940 Reduced 50.98%	339,387 $21.4 Million
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $20.1 Million - $23.3 Million	-277,655 Reduced 28.62%	692,327 $53.3 Million
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $614,087 - $786,557	9,805 Added 1.02%	969,982 $72.5 Million
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $2.31 Million - $2.54 Million	37,524 Added 4.07%	960,177 $62.4 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $1.16 Million - $1.28 Million	18,500 Added 2.05%	922,653 $58.5 Million
Q2 2019 Aug 06, 2019	BUY	$61.87 - $69.38 $4.53 Million - $5.08 Million	73,290 Added 8.82%	904,153 $61.1 Million
Q1 2019 May 09, 2019	SELL	$62.53 - $70.05 $43,145 - $48,334	-690 Reduced 0.08%	830,863 $54 Million
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $204,625 - $267,020	3,380 Added 0.41%	831,553 $52 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $4.29 Million - $4.75 Million	60,206 Added 7.84%	828,173 $63.9 Million
Q2 2018 Aug 08, 2018	BUY	$64.88 - $75.68 $3.11 Million - $3.63 Million	47,970 Added 6.66%	767,967 $54.4 Million
Q1 2018 May 07, 2018	BUY	$72.84 - $88.8 $2.88 Million - $3.51 Million	39,517 Added 5.81%	719,997 $54.3 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $7.28 Million - $8.54 Million	102,310 Added 17.7%	680,480 $48.8 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $41.7 Million - $49.4 Million	578,170	578,170 $46.8 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mawer Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mawer Investment Management Ltd. with notifications on news.

Account